Friday, April 12, 2024

Twilight zone market: Oil, Gold and Silver and just one bio- spec (some , not too much stock)

 Market Talk                                


The Fed 2% target rate of inflation to determine interest rates may be a thing of the past, a figment of the imagination as Rod Sterling would say. Yes, the market may feel like the twilight zone to us retail little people that try to follow the twists and turns of market sentiments that can move stocks either way .  Bulls and bears debate the coming Fed interest rate moves and the effects on the economy.

Alas, what is real and what is not real to you may depend on your world view as you try to trade or invest in stocks and project performance into the future.

What is working and not working?


 Stock Talk


As the market sells off on a Friday close,  we note that many stocks are trading off.  It's near jerk Friday. World tensions are heating up.

For now, we stay the course on some that are working and see how things play out. Of course, these are not buy/sell recommendations. But, they've been working and have potential to keep on working in time to come. --  dips may be opportunity.

Energy, OIL - Devon Energy (DVN) is one pick to watch.

GOLD is running warm and then hot since listed here on the Jones report.

  -- some Gold etf's : GLD,  GLDM , SLV,  ULG,

SILVER 

  -- some Silver etf's:  SLV, AGC

 and Gold miners: GOLDKGC

   maybe some Crypto etf's:   IBIT, EZBC  (on dips)

and a spec biotech near a buck a share?  ONCY

  - maybe just a 100 or 200 shares of ONCY at just over a buck? 

ONCY is a spec stock near a buck and a "not too much" stock here.  ONCY may be positioning itself for a Big Pharma partner or takeover on their lead drug, Pelareorep.  The aim of "Pela" is to fight and kill cancer cells by boosting T fighter cells of patient's own immune system to target dangerous cancers . There is scan evidence that it works to duplicate T fight cells to target cancers. Oncy is planning confirmation trials that could impress big Pharma to make a move on ONCY and Pelareorep in a partnership or buyout.  Some point to possible interest by Merck KG in Germany because of their past involvement is T fight cell activation to target and kill cancer cells.

If interested, scroll back a few posts for more coverage on any of the above topics.  In all -  we use the word maybe "some", not "too much" and play it accordingly.  Remember  never get arrogant in our various  notions because things do change in the market and individual stocks are subject to many factors outside of our control.. So we try to -stay aware.

For now, we close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________